Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL39307/0056.
Metoclopramide hydrochloride 5mg/5ml Oral Solution
Metoclopramide hydrochloride 5mg/5ml
Oral Solution
The name of the medicine is Metoclopramide hydrochloride 5mg/5ml Oral Solution but it will be referred to as Metoclopramide throughout this leaflet.
1. What Metoclopramide is and what it is used for
2. What you need to know before you take Metoclopramide
3. How to take Metoclopramide
4. Possible side effects
5. How to store Metoclopramide
6. Contents of the pack and other information
Metoclopramide is an antiemetic. It works on a part of your brain that prevents you from feeling sick (nausea) or being sick (vomiting).
Adult population:
Metoclopramide is used in adults:
Metoclopramide can be taken with oral painkillers in case of migraine to help painkillers work more effectively.
Paediatric population:
Metoclopramide is indicated in children (aged 1-18 years) if other treatments do not work or cannot be used to prevent delayed nausea and vomiting that may occur after chemotherapy.
You must talk to a doctor if you do not feel better or if you feel worse.
Do not give Metoclopramide to a child less than 1 year of age (see below “Children and adolescents”).
Do not take Metoclopramide if any of the above statements apply to you, or that have applied to you in the past. If in doubt, consult your doctor or pharmacist before taking Metoclopramide.
Talk to your doctor, pharmacist or nurse before taking Metoclopramide if:
Your doctor may perform blood tests to check your blood pigment levels. In cases of abnormal levels (methaemoglobinemia), the treatment should be immediately and permanently stopped.
You must wait at least 6 hours between each metoclopramide dose, even in case of vomiting and rejection of the dose, in order to avoid overdose.
Do not exceed 3-month treatment because of the risk of involuntary muscle spasms.
Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults. This solution must not be used in children below 1 year of age because of the increased risk of the uncontrollable movements (see above “Do not take Metoclopramide if”).
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This is because some medicines can affect the way Metoclopramide works or Metoclopramide can affect how other medicines work. These medicines include the following:
Alcohol should not be consumed during treatment with metoclopramide because it increases the effect of drowsiness and sleepiness.
Pregnancy:
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. If necessary, Metoclopramide may be taken during pregnancy. Your doctor will decide whether or not you should be given this medicine.
Breast-feeding:
Metoclopramide is not recommended if you are breast-feeding because metoclopramide passes into breast milk and may affect your baby.
You may feel drowsy, dizzy or have uncontrollable twitching, jerking or writhing movements and unusual muscle tone causing distortion of the body after taking Metoclopramide. This may affect your vision and also interfere with your ability to drive and use machines.
Sodium benzoate (E211): This medicine contains 1.25mg sodium benzoate in each 5ml which is equivalent to 0.25mg/ml.
Sodium: This medicine contains less than 1 mmol sodium (23 mg) per 5ml, that is to say essentially “sodium-free” .
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Adult population:
The recommended single dose is 10 mg, repeated up to three times daily.
The maximum recommended dose per day is 30 mg or 0.5 mg/kg body weight.
The maximum recommended treatment duration is 5 days.
To prevent delayed nausea and vomiting that may occur after chemotherapy (children aged 1-18 years):
The recommended dose is 0.1 to 0.15 mg/kg body weight, repeated up to 3 times daily, taken orally.
The maximum dose in 24 hours is 0.5 mg/kg body weight.
Dosing table
For children aged 1-3 years (body weight 10-14 kg) the dose is 1 mg up to 3 times daily.
For children aged 3-5 years (body weight 15-19 kg) the dose is 2 mg up to 3 times daily.
For children aged 5-9 years (body weight 20-29 kg) the dose is 2.5 mg up to 3 times daily.
For children aged 9-18 years (body weight 30-60 kg) the dose is 5 mg up to 3 times daily.
For children aged 15-18 years (body weight over 60 kg) the dose is 10 mg up to 3 times daily.
You should not take this medicine for more than 5 days to prevent delayed nausea and vomiting that may occur after chemotherapy.
The dose may need to be reduced depending on kidney problems, liver problems and overall health.
Talk to your doctor if you have kidney problems. The dose should be reduced if you have moderate or severe kidney problems.
Talk to your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.
Metoclopramide must not be used in children aged less than 1 year (see section 2).
You must wait at least 6 hours between each metoclopramide dose, even in the case of vomiting or rejection of the dose, in order to avoid overdose.
This medicine must be taken orally.
Use the measuring syringe provided in the pack to deliver the required dose.
Instructions for the use of syringe:
a) Open the bottle: press the cap and turn it anticlockwise (Figure 1).
b) Separate the adaptor from the syringe (Figure 2). Insert the adaptor into the bottle neck (Figure 3). Ensure it is properly fixed. Take the syringe and put it in the adaptor opening (Figure 4).
c) Turn the bottle upside down. Fill the syringe with a small amount of solution by pulling the piston down (Figure 5A), then push the piston upwards in order to remove any possible air bubbles (Figure 5B). Pull the piston down to the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor (Figure 5C).
d) Turn the bottle the right way up (Figure 6A). Remove the syringe from the adaptor (Figure 6B).
e) Empty the contents of the syringe into the patient’s mouth by pushing the piston to the bottom of the syringe (Figure 7). The contents of the syringe should be emptied into the side cheek of the patient’s mouth to avoid a choking hazard. Leave the syringe adaptor in place after first use. Close the bottle with the plastic screw cap. Wash the syringe with water (Figure 8). Repeat the above steps if required dose is more than 5ml.
Contact your doctor or pharmacist straight away. You may experience uncontrollable movements (extrapyramidal disorders), feel drowsy, have some troubles of consciousness, be confused, have hallucinations and heart problems. Your doctor may prescribe you a treatment for these signs if necessary.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop the treatment and talk to your doctor, pharmacist or nurse straight away if you experience one or more of the following signs while taking this medicine:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in this leaflet.
Reporting of side effects:
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Each 5ml of oral solution contains 5mg metoclopramide hydrochloride (anhydrous).
The other ingredients are: sodium benzoate (E211), citric acid monohydrate (E330), sodium citrate (E331), saccharin sodium (E954), lemon flavour 13499 (containing propylene glycol (E1520), natural flavouring substances and flavouring preparation) and purified water.
Metoclopramide is a clear, colourless oral solution with lemon flavour supplied in an amber glass bottle with a tamper evident, child resistant plastic cap. The pack also comes with a 5ml oral syringe with 0.2ml graduation for measuring the dose and a syringe adaptor for bottle.
Metoclopramide hydrochloride oral solution is supplied in a bottle containing 150ml solution.
If this leaflet is hard to see or read, please call +44 (0) 208 515 3700 for help.
This leaflet was revised in 03/2025.
PIL/UK/MFG112/02/SMD/v4